Get Ready for Canopy Growth (TSX:WEED) to Soar

Cannabis stocks have gone up and down, but undervalued Canopy Growth Corp (TSX:WEED)(NYSE:CGC) should remain at the top of your buy list.

| More on:

If you’re fairly tuned into what topics are trending within the world of investing, you’ve probably already noticed a pretty odd scenario. On the one hand, we have passive-income dividend stocks making a mark, and on the other we have cannabis stocks continuing to take a place at the table.

Now, it might seem odd, as one is focused on long-term gains through both steady share increases and annual dividend income, and the other is still a risky bet on a new industry. But really, it shouldn’t be that strange.

In fact, it shows that millennials are finally showing an interest in the stock market and educating themselves about it. Rather than putting all their cash into a risky business, they’re coupling it with dividend stocks, making for a more diverse portfolio.

This should be great news to the cannabis industry, as it means these investors now have money in one location making steady increases and can use their other funds towards the more exciting — and yes, risky — industries such as cannabis.

Well, if you’re going to choose one cannabis stock to jump on today, I’d go with the industry’s market leader: Canopy Growth (TSX:WEED)(NYSE:CGC). Shares remain slumped after an incredible summer last year, but it isn’t just low share prices that have analysts thinking this stock is undervalued and set to explode.

First, there is the marijuana market as a whole. It’s not just a Canadian phenomenon, but rather a global-sized enterprise that G20 countries are all considering. More than 40 countries already allow the legal use of cannabis in some way or another, so when consumers can purchase it across Europe and North America, this will be an enormous opportunity for cannabis companies to come away as titans of the potentially $150 billion industry.

Number one on that list would be a company like Canopy Growth, which already has a huge piece of the industry pie. Canopy Growth has made acquisition after acquisition, partnering with companies like Constellation Brands to be in every part of the marijuana industry: medical marijuana, recreational marijuana, hemp cannabidiol (CBD), edibles, even makeup. Canopy Growth doesn’t look like it’ll be missing out on any opportunity within the cannabis industry.

No wonder the company has been ramping up production across North America to achieve this potential for growth. The firm has been keeping its numbers fairly tight to the chest, but it’s estimated the company can produce about 550,000 kilograms of marijuana annually. While some analysts think this much marijuana could create a glut in the market, Canopy Growth is thinking long term. As soon as Europe and, more lucratively speaking, the United States legalize marijuana, they will be ready to pump out pot across the world.

With all of these announcements, goals, and growth, it’s no wonder that investors are anxiously anticipating the company’s earnings report. The few that have been released have been a bit of a mixed bag, so investors are more than just curious as to where Canopy Growth lies. Sales were slow to the start of 2019, making analysts downgrade expectations.

It seems those expectations were realized when Canopy Growth announced its Q4 results. While the company saw a 13% rise in net revenue compared to last quarter, beating expectations, its net loss jumped to $335.6 million.

Foolish takeaway

Frankly, I wouldn’t dwell on quarterly results when it comes to Canopy Growth. The firm has a way to go before it makes some serious profit, and while it’s well on the way through long-term growth, it won’t be until major announcements come through that its shares will sky rocket. The problem is, investors will have to be patient. They will have to wait for G20 countries and, most importantly, the U.S. to legalize marijuana to see the full potential that Canopy Growth has to offer.

But that patience will surely be rewarded. Canopy Growth remains at the top of the industry ladder. Shares will likely continue to climb as quarterly reports slowly improve. With shares still undervalued as of writing, now is the perfect time to pick up the stock.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of Canopy Growth.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »